Abouzid, Khaled

khaled.abouzid@pharma.asu.edu.eg

Department of Pharmaceutical Chemistry - Pharmacy
Interests: Anticancer drug discovery, design and synthesis, Antimicrobial,
Internal ID: rp12178
  • 3,121 Scopus Citations
  • 592 PubMed Citations

Loading... 2 0 20 0 false
 
khaled__.jpg picture
 
Full Name
Abouzid, Khaled
 
 
Personal Site
 
 
Scopus Author ID
 
WOS ID
 
Biography
Dr. Khaled Abouzid is a Professor of Pharmaceutical Chemistry, Faculty of Pharmacy, Ain Shams University, Prominent Scholar in Drug Discovery, Co-founding Director of Center of Drug Discovery and Development Research ASU He was nominated as the Acting Dean of the Faculty of Pharmacy, University of Sadat City from 8-2018 to 8-2022. He is currently a member of national pharmaceutical chemistry promotion committee
Dr. Abouzid’s research is directed towards drug discovery of bioactive small molecules with special emphasis on cannabinoids, targeted anticancer, anti-inflammatory, anti-viral anti-microbial agents and enzyme inhibitors. He has published over 150 research papers, two books and filed 14 patents in medicinal chemistry. He has Scopus H index of 28. He has supervised over 100 Master and PhD students in 7 universities. Dr Abouzid has research collaborations with German, British, Swedish, Canadian and US universities. He has also organized and presided over 34 international symposia and conferences.
Dr. Abouzid obtained his B.Sc. degree in Pharmaceutical Sciences from Cairo University in 1985, and his PhD. joint degree in Organic Chemistry from the Faculty of Pharmacy, Cairo University and School of Pharmacy University of Connecticut, USA.
Dr. Abouzid started his career in 1995 as a lecturer of Organic Chemistry at Cairo University, Faculty of Pharmacy. In 2001, he moved to the Department of Pharmaceutical Chemistry, Ain Shams University, and was promoted to Associate Professor in 2003. He did postdoctoral work with Professor Jochen Lehman of the Friedrich-Schiller-Universität Jena, Germany.

Publications

Results 21-40 of 134 (Search time: 0.005 seconds).

Issue DateTitleAuthor(s)
212021Lipid polymer hybrid nanocarriers as a combinatory platform for different anti-SARS-CoV-2 drugs supported by computational studiesAbdel-Bar, Hend Mohamed; Abdallah, Inas A.; Fayed, Marwa A. A.; Moatasim, Yassmin; Mostafa, Ahmed; El-Behairy, Mohammed Farrag; Elimam, Hanan; Elshaier, Yaseen A. M. M.; Abouzid, Khaled 
222021Synthesis, In Silico and In Vitro Antimicrobial Evaluation of Cyanoketene S,N-Acetals and Their Pyrazoles Against Staphylococcus Aureus DNA Gyrase EnzymeAli, Shimaa; H.I. Faraag, Ahmed; Elgiushy, Hossam; Said, Taghred; askar, ahmed; Hassan, ashraf; Abouzid, Khaled ; Fouad, Sherif
23Dec-2020Design, synthesis and biological evaluation of a new thieno[2,3-d]pyrimidine-based urea derivative with potential antitumor activity against tamoxifen sensitive and resistant breast cancer cell linesSharaky, Marwa; Kamel, Marwa; Aziz, Marwa A; Omran, Mervat; Rageh, Monira M; Abouzid, Khaled ; Shouman, Samia A
241-Sep-2020An investigative study of antitumor properties of a novel thiazolo[4,5-d]pyrimidine small molecule revealing superior antitumor activity with CDK1 selectivity and potent pro-apoptotic propertiesMohamed, Sameh H; Elgiushy, Hossam R; Hammad, Sherif F; Abou-Taleb, Nageh A; A M Abouzid, Khaled; Abouzid, Khaled ; Hassan, Zeinab; Ali Taha, Heba
2526-Aug-2020Elaborating piperazinyl-furopyrimidine based scaffolds as phosphoinositol-3-kinase enzyme alpha (PI3Kα) inhibitors to combat pancreatic cancerMansour, Mai A; Lasheen, Deena S. ; Gaber, Hatem M; Khaled A M Abouzid 
2618-Aug-2020Design, Synthesis, and Biological Evaluation of Novel 7H-[1,2,4]Triazolo[3,4-b][1,3,4]thiadiazine Inhibitors as Antitumor AgentsIsmail, Muhammad I; Mohamady, Samy; Samir, Nermin; Abouzid, Khaled 
2710-Aug-2020Design, synthesis and in silico studies of new quinazolinone derivatives as antitumor PARP-1 inhibitorsRamadan, Sayed ; Elrazaz, Eman ; Khaled A M Abouzid ; El- naggar, Abeer 
281-Aug-2020Penicillin binding protein 2a: An overview and a medicinal chemistry perspectiveShalaby, Menna-Allah W; Dokla, Eman ; Serya, Rabah ; Khaled A M Abouzid 
29Aug-2020Scaffold hopping and redesign approaches for quinazoline based urea derivatives as potent VEGFR-2 inhibitorsHadi, Soha R Abd El; Soliman, Dalia H; Elrazaz, Eman ; Khaled A M Abouzid ; Lasheen, Deena S. 
309-Apr-2020Targeting YAP Degradation by a Novel 1,2,4-Oxadiazole Derivative via Restoration of the Function of the Hippo PathwayDokla, Eman ; Fang, Chun Sheng; Chu, Po Chen; Chang, Chih Shiang; Chen, Ching S.; Khaled A M Abouzid 
3115-Jan-2020Development of benzimidazole-based derivatives as antimicrobial agents and their synergistic effect with colistin against gram-negative bacteriaAbutaleb, Nader S; Milik, Sandra N; Li, Daoyi; El-Baz, Karim; Shalaby, Menna-Allah W; Al-Karaki, Rawan; Nasr, Maha ; Klein, Christian D; Seleem, Mohamed N; Dokla, Eman ; Khaled A M Abouzid 
32Jan-2020Design, synthesis, biological evaluation and molecular modeling study of new thieno[2,3-d]pyrimidines with anti-proliferative activity on pancreatic cancer cell linesSalem, Mohamed S H; Abdel Aziz, Yasmine M; Elgawish, Mohamed S; Said, Mohamed M; Abouzid, Khaled 
33Jan-2020Synthesis and antimicrobial evaluation of new halogenated 1,3-Thiazolidin-4-onesHammad, Shaymaa G; El-Gazzar, Marwa G; Abutaleb, Nader S; Li, Daoyi; Ramming, Isabell; Shekhar, Aditya; Abdel-Halim, Mohammad; Elrazaz, Eman ; Seleem, Mohamed N; Bilitewski, Ursula; El-Hossary, Ebaa M; Khaled A M Abouzid 
342020Synthesis, Biological Evaluation and In Silico Investigation of Novel Functionalized Imidazole-Based KDM6 InhibitorsSerya, Rabah ; El-Araby, Amr; Qassem, Omar; El-Sawy, Ezzat; El-Razaz, Eman; Abouzid, Khaled 
351-Dec-2019Phosphatidylinositol 3 kinase (PI3K) inhibitors as new weapon to combat cancerElmenier, Fatma M; Lasheen, Deena S. ; Khaled A M Abouzid 
36Dec-2019Towards discovery of novel scaffold with potent antiangiogenic activity; design, synthesis of pyridazine based compounds, impact of hinge interaction, and accessibility of their bioactive conformation on VEGFR-2 activitiesJaballah, Maiy Y; Serya, Rabah ; Saad, Nasser; Khojah, Sohair M; Ahmed, Marawan; Barakat, Khaled; Khaled A M Abouzid 
3715-Nov-20191,2,4-Oxadiazole derivatives targeting EGFR and c-Met degradation in TKI resistant NSCLCDokla, Eman ; Fang, Chun Sheng; Chen, Ching S.; Abouzid, Khaled 
38Aug-20193D-QSAR pharmacophore modelling, virtual screening and docking studies for lead discovery of a novel scaffold for VEGFR 2 inhibitors: Design, synthesis and biological evaluationSobhy, Mahitab K; Mowafy, Samar; Lasheen, Deena S. ; Farag, Nahla A; Khaled A M Abouzid 
3925-Mar-2019Design and Synthesis of New Quinoxaline Derivatives as Anticancer Agents and Apoptotic InducersEl Newahie, Aliya M S; Nissan, Yassin M; Ismail, Nasser S M; Abou El Ella, Dalal ; Khojah, Sohair M; Abouzid, Khaled 
40Mar-2019Design, synthesis and molecular modeling study of certain VEGFR-2 inhibitors based on thienopyrimidne scaffold as cancer targeting agentsGhith, Amna; Youssef, Khairia M; Ismail, Nasser S M; Abouzid, Khaled